Skip to main content
Bristol Myers SquibbPatent grant

Bristol-Myers Squibb was granted a patent for crystalline drug forms.

Source: Autobound Signal API · 118 signals tracked for Bristol Myers Squibb · updated

Get Bristol Myers Squibb's live signals in Claude or ChatGPT, or by API

AskWhat changed at Bristol Myers Squibb this week? Use Autobound signals for bms.com.

What happened

In November 2026 Bristol-Myers Squibb patented salt and crystal forms of a small-molecule compound for pharmaceutical development and medicine manufacturing.

Source

Extracted by Autobound

From the Signal API record
Signal
Patent grant

What this signalsA new patent often shows where a company is putting its R&D budget.

Grant date
Nov 17, 2026
Inventors
3
Patent number
US12799114
Assignee
BRISTOL-MYERS SQUIBB COMPANY

The full record

From the Signal API record

People

  • Prashant Mrityunjaya Sujata KameshwarInventor
  • Roopa NarasimhamurthyInventor
  • Qi GaoInventor
  • Jennifer NelsonInventor

Details

Primary CPC class
C07D 471/04
USPTO assignee
BRISTOL-MYERS SQUIBB COMPANY
What the invention does
A protected chemical compound prepared in different salt and crystal arrangements to help produce and formulate a potential medicine consistently.

Topics and mentions

Tags

  • Intellectual Property
  • Research & Development
  • Pharmaceuticals
  • Chemical Engineering

Technologies named

  • medicinal chemistry
  • small-molecule therapeutics
  • crystal formulation

Extraction

Detected
Nov 18, 2026
signal_type
patents-company
signal_subtype
patentGrant

Use this data

Get every patent signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”

  2. Send it to your own tools

    The Signal API returns patent signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full patents-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/8ef9b3ac-3241-51d2-80a0-7a0ad27fcb07 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.

{
  "signal_id": "8ef9b3ac-3241-51d2-80a0-7a0ad27fcb07",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-11-18T15:06:52+00:00",
  "company": {
    "name": "Bristol Myers Squibb",
    "domain": "bms.com"
  },
  "data": {
    "cpc": [
      {
        "code": "C07D 471/04"
      },
      {
        "code": "A61K 31/4545"
      },
      {
        "code": "C07C 309/29"
      },
      {
        "code": "C07B 2200/13"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Pharmaceuticals",
      "Chemical Engineering"
    ],
    "detail": "In November 2026 Bristol-Myers Squibb patented salt and crystal forms of a small-molecule compound for pharmaceutical development and medicine manufacturing.",
    "summary": "Bristol-Myers Squibb was granted a patent for crystalline drug forms.",
    "event_at": "2026-11-17",
    "inventors": [
      {
        "name": "Prashant Mrityunjaya Sujata Kameshwar",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/prashant-kameshwar-a96ab027"
      },
      {
        "name": "Roopa Narasimhamurthy",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Qi Gao",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Jennifer Nelson",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-11-17",
    "source_url": "https://patents.google.com/patent/US12799114",
    "cpc_primary": {
      "code": "C07D 471/04"
    },
    "patent_title": "2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide salt and crystalline forms thereof",
    "patent_number": "US12799114",
    "uspto_assignee": "BRISTOL-MYERS SQUIBB COMPANY",
    "patent_abstract": "Disclosed are salts of 2-(4-(2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a] pyridin-6-yl)-3-isopropyl-1H-indol-5-yl)piperidin-1-yl)acetamide and crystalline forms thereof.",
    "precision_class": "structural",
    "invention_explanation": "A protected chemical compound prepared in different salt and crystal arrangements to help produce and formulate a potential medicine consistently.",
    "technologies_mentioned": [
      "medicinal chemistry",
      "small-molecule therapeutics",
      "crystal formulation"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.